Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-08-15

FDA Approved: MELOXICAM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for MELOXICAM from Zydus Pharmaceuticals USA Inc., granting approval to market generic meloxicam in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MELOXICAM (MELOXICAM)

Snippet

SUPPL AP for MELOXICAM (MELOXICAM)